asthma response acting receptors beta2ar displays extensive interindividual variation effector airway beta2ar adenylyl cyclase type NUMBER ac9 considered candidate locus predicting efficacy absence presence corticosteroid treatment ac9 polymorphism identified results substitution met ile amino acid NUMBER standard culture conditions stably transfected cells decreased catalytic activity met772 cells cultured presence glucocorticoid expressing met772 significantly increased adenylyl cyclase response approximately NUMBER compared expressing ile772 approximately NUMBER p002 equivalent increase beta2ar expression observed lines glucocorticoid ac9 expression unaffected hypothesis associated improved albuterol bronchodilator response asthmatics investigated NUMBER asthmatic children followed NUMBER years randomized receive placebo inhaled corticosteroid budesonide met772 carriers budesonide showed significant improvement forced expiratory volume NUMBER s p0005 highly significant interaction p0002 budesonide treatment ac9 polymorphism vitro human association studies consistent ac9 polymorphism altering albuterol responsiveness context concomitant inhaled corticosteroid administration common asthma regimen polymorphism represents likely polymorphisms axis provide composite pharmacogenetic index asthma therapy beta agonists beta2 adrenergic beta agonist non synonymous albuterol stimulated met772 ac9 met772 ac9 multi gene receptor relaxation